FDA Brief

Warning letters Drugs

FDA warning letter to

Darmerica, LLC

Issued Dec 8, 2025Posted Dec 23, 2025Center for Drug Evaluation and Research (CDER)

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded. We haven't summarized this letter yet. Read it on fda.gov.